We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
An uncertain future? It may be a difficult time for cardiovascular drug development, but there are still reasons to be positive, say Koos Burggraaf and Matthijs Moerland at the Centre for Human Drug Research.